200 related articles for article (PubMed ID: 11059479)
1. Determining the area under the ROC curve for a binary diagnostic test.
Cantor SB; Kattan MW
Med Decis Making; 2000; 20(4):468-70. PubMed ID: 11059479
[TBL] [Abstract][Full Text] [Related]
2. Area under the ROC curve for a binary diagnostic test.
Desbiens NA
Med Decis Making; 2001; 21(5):421-2. PubMed ID: 11575492
[No Abstract] [Full Text] [Related]
3. The area under an ROC curve with limited information.
van den Hout WB
Med Decis Making; 2003; 23(2):160-6. PubMed ID: 12693878
[TBL] [Abstract][Full Text] [Related]
4. [ROC (receiver operating characteristics) curve: principles and application in biology].
Delacour H; Servonnet A; Perrot A; Vigezzi JF; Ramirez JM
Ann Biol Clin (Paris); 2005; 63(2):145-54. PubMed ID: 15771972
[TBL] [Abstract][Full Text] [Related]
5. Sample size calculations in studies of test accuracy.
Obuchowski NA
Stat Methods Med Res; 1998 Dec; 7(4):371-92. PubMed ID: 9871953
[TBL] [Abstract][Full Text] [Related]
6. Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection.
Hoffman RM; Clanon DL; Chavez M; Peirce JC
Prostate; 2002 Jul; 52(2):150-8. PubMed ID: 12111706
[TBL] [Abstract][Full Text] [Related]
7. A procedure for determining whether a simple combination of diagnostic tests may be noninferior to the theoretical optimum combination.
Jin H; Lu Y
Med Decis Making; 2008; 28(6):909-16. PubMed ID: 18556633
[TBL] [Abstract][Full Text] [Related]
8. [Clinical use of diagnostic tests (Part 1): Analysis of the properties of a diagnostic test].
Cerda L J; Cifuentes A L
Rev Chilena Infectol; 2010 Jun; 27(3):205-8. PubMed ID: 20737121
[TBL] [Abstract][Full Text] [Related]
9. Assessing the diagnostic accuracy of a sequence of tests.
Thompson ML
Biostatistics; 2003 Jul; 4(3):341-51. PubMed ID: 12925502
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic likelihood ratios].
Capron L
Rev Prat; 2000 Nov; 50(17):1865-9. PubMed ID: 11151325
[No Abstract] [Full Text] [Related]
11. A mixed model approach to meta-analysis of diagnostic studies with binary test outcome.
Doebler P; Holling H; Böhning D
Psychol Methods; 2012 Sep; 17(3):418-36. PubMed ID: 22582866
[TBL] [Abstract][Full Text] [Related]
12. Point and interval estimation of accuracies of a binary medical diagnostic test following group sequential testing.
Shu Y; Liu A; Li Z
Philos Trans A Math Phys Eng Sci; 2008 Jul; 366(1874):2335-45. PubMed ID: 18407894
[TBL] [Abstract][Full Text] [Related]
13. Combining biomarkers to detect disease with application to prostate cancer.
Etzioni R; Kooperberg C; Pepe M; Smith R; Gann PH
Biostatistics; 2003 Oct; 4(4):523-38. PubMed ID: 14557109
[TBL] [Abstract][Full Text] [Related]
14. [The influence of prostate volume on the diagnostic parameters related to PSA and clinicopathological features of prostate cancer].
Kimura G; Kimata R; Saito Y; Yoshida K; Nishimura T
Nihon Rinsho; 2002 Dec; 60 Suppl 11():479-85. PubMed ID: 12599623
[No Abstract] [Full Text] [Related]
15. Interpreting diagnostic accuracy studies for patient care.
Mallett S; Halligan S; Thompson M; Collins GS; Altman DG
BMJ; 2012 Jul; 345():e3999. PubMed ID: 22750423
[No Abstract] [Full Text] [Related]
16. Receiver operating characteristic (ROC) curve for medical researchers.
Kumar R; Indrayan A
Indian Pediatr; 2011 Apr; 48(4):277-87. PubMed ID: 21532099
[TBL] [Abstract][Full Text] [Related]
17. Re: Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
Stephan C; Jung K; Lein M; Schnorr D; Loening SA
J Urol; 2000 Nov; 164(5):1671-2. PubMed ID: 11203074
[No Abstract] [Full Text] [Related]
18. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
19. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
Finne P; Zhang WM; Auvinen A; Leinonen J; Määttänen L; Rannikko S; Tammela TL; Stenman UH
J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890
[TBL] [Abstract][Full Text] [Related]
20. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
N Engl J Med; 2003 Jul; 349(4):335-42. PubMed ID: 12878740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
